In our study, abnormal bone mineral density was the most commonly reported adverse event among musculoskeletal and connective tissue disorders, followed by three others: increased blood parathyroid hormone, decreased N-terminal prepeptide of serum type I procollagen, and increased ant tartaric acid phosphatase. The gene discussed is PTH; the disease is connective tissue disorder.